Marshall Wace LLP lifted its place in Fresenius Medical Care AG (NYSE:FMS – Free Report) by 8.5% within the second quarter, in response to its most up-to-date Kind 13F submitting with the Securities and Change Fee. The agency owned 15,363 shares of the corporate’s inventory after buying an extra 1,207 shares in the course of the quarter. Marshall Wace LLP’s holdings in Fresenius Medical Care had been price $293,000 on the finish of the latest reporting interval.
Different hedge funds have additionally lately modified their holdings of the corporate. GAMMA Investing LLC boosted its stake in Fresenius Medical Care by 21.8% in the course of the first quarter. GAMMA Investing LLC now owns 4,230 shares of the corporate’s inventory price $82,000 after shopping for an extra 758 shares in the course of the interval. Wulff Hansen & CO. lifted its place in shares of Fresenius Medical Care by 1,809.0% in the course of the second quarter. Wulff Hansen & CO. now owns 343,429 shares of the corporate’s inventory price $6,556,000 after buying an extra 325,439 shares within the final quarter. QRG Capital Administration Inc. lifted its place in shares of Fresenius Medical Care by 19.5% in the course of the first quarter. QRG Capital Administration Inc. now owns 54,363 shares of the corporate’s inventory price $1,048,000 after buying an extra 8,870 shares within the final quarter. SG Americas Securities LLC lifted its place in shares of Fresenius Medical Care by 50.0% in the course of the first quarter. SG Americas Securities LLC now owns 15,228 shares of the corporate’s inventory price $294,000 after buying an extra 5,078 shares within the final quarter. Lastly, Legacy Wealth Asset Administration LLC acquired a brand new stake in shares of Fresenius Medical Care in the course of the first quarter price about $584,000. Hedge funds and different institutional buyers personal 8.25% of the corporate’s inventory.
Fresenius Medical Care Inventory Down 1.4 %
FMS inventory opened at $19.60 on Friday. The corporate has a present ratio of 1.46, a fast ratio of 1.09 and a debt-to-equity ratio of 0.45. Fresenius Medical Care AG has a twelve month low of $16.37 and a twelve month excessive of $22.76. The corporate’s 50 day shifting common is $19.82 and its two-hundred day shifting common is $20.03. The inventory has a market cap of $11.50 billion, a P/E ratio of 20.25, a PEG ratio of 1.06 and a beta of 0.91.
Fresenius Medical Care (NYSE:FMS – Get Free Report) final launched its quarterly earnings information on Tuesday, July thirtieth. The corporate reported $0.38 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.38. The corporate had income of $5.13 billion for the quarter, in comparison with analysts’ expectations of $5.28 billion. Fresenius Medical Care had a web margin of two.72% and a return on fairness of 5.48%. Analysis analysts anticipate that Fresenius Medical Care AG will submit 1.52 earnings per share for the present fiscal yr.
Analyst Upgrades and Downgrades
FMS has been the subject of a number of analyst stories. StockNews.com initiated protection on shares of Fresenius Medical Care in a report on Tuesday. They issued a “strong-buy” ranking on the inventory. Truist Monetary raised their goal value on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the corporate a “maintain” ranking in a report on Monday, October seventh. One analyst has rated the inventory with a promote ranking, two have given a maintain ranking, one has issued a purchase ranking and one has assigned a robust purchase ranking to the inventory. Primarily based on information from MarketBeat, the inventory has a mean ranking of “Maintain” and a mean value goal of $23.00.
Learn Our Newest Analysis Report on Fresenius Medical Care
Fresenius Medical Care Firm Profile
Fresenius Medical Care AG supplies dialysis and associated companies for people with renal ailments in Germany, North America, and internationally. The corporate affords dialysis remedy and associated laboratory and diagnostic companies via a community of outpatient dialysis clinics; supplies, coaching, and affected person help companies comprising scientific monitoring, follow-up help, and arranging for supply of the provides to the affected person’s residence; and dialysis companies beneath contract to hospitals in the US for the hospitalized end-stage renal illness (ESRD) sufferers and for sufferers affected by acute kidney failure.
Featured Tales
Wish to see what different hedge funds are holding FMS? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Fresenius Medical Care AG (NYSE:FMS – Free Report).
Obtain Information & Scores for Fresenius Medical Care Each day – Enter your electronic mail tackle beneath to obtain a concise each day abstract of the most recent information and analysts’ scores for Fresenius Medical Care and associated corporations with MarketBeat.com’s FREE each day electronic mail publication.
